Continuous subcutaneous injection of fentanyl for titration of cancer pain: a retrospective study

Continuous subcutaneous injection of fentanyl for titration of cancer pain: a retrospective study - Continuous subcutaneous injection of fentanyl

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046588

Enrollment

Registered

2022-02-15

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to severe cancer pain

Interventions

CSCI of fentanyl (less than 2 weeks).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To have moderate to severe cancer pain.

Exclusion criteria

Exclusion criteria: non-titration purpose, non-cancer pain, and mild pain NRS less than 5.

Design outcomes

Primary

Measure	Time frame
Rate of titration completion.	—

Secondary

Measure	Time frame
Perioid of titration. Rate of more than 66% response of average numerical rating scale (NRS) of pain.	—

Countries

Japan

Contacts

Public ContactTatsuma Sakaguchi

Kitano Hospital, Tazuke Kofukai Medical Research Institute Division of palliative care

sakaguchi.tatsuma@gmail.com0663121221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026